Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Michael Tarantino, James B. Bussel, MD, Victor S. Blanchette, MD, Donald Beam, John Roy, Jenny M. Despotovic, DO, MS, Ashok Raj, Nancy Carpenter, Bhakti Mehta, Melissa Eisen

Blood (2017) 130 (Supplement 1): 14.

https://doi.org/10.1182/blood.V130.Suppl_1.14.14

Published: 2017

Journal Articles

Validation of the Modified Self-Administered Pediatric Bleeding Assessment Questionnaire (Self-PBQ) in Children Aged 8-12 Years

Jessica Bui, BHSc, David Martyres, Paula D. James, MD, Julie Grabell, CCRP, John K. Wu, MBBS, FRCPC, MS, MacGregor Steele, MD FRCP(C), Mariana Silva, MD FRCPC, Margaret L. Rand, PhD, Victor S. Blanchette, MD, Robert J Klaassen, MD FRCPC

Blood (2017) 130 (Supplement 1): 2135.

https://doi.org/10.1182/blood.V130.Suppl_1.2135.2135

Published: 2017

Journal Articles

Results from a Prospective, Dose Escalating, Prophylaxis Study in Young Boys with Severe Hemophilia a in China: The China Hemophilia Individualized Prophylaxis Study (CHIPS) (NCT02999308)

Blood (2017) 130 (Supplement 1): 3683.

https://doi.org/10.1182/blood.V130.Suppl_1.3683.3683

Published: 2017

Journal Articles

Use of Bleeding Assessment Tools in the Diagnosis of Von Willebrand Disease: Are We Asking the Right Questions?

Jordan Spradbrow, BSc, Sasha Letourneau, Julie Grabell, CCRP, Yupu Liang, PhD, James Riddel, RN, MS, CPNP, Wilma Hopman, MSc, Victor S. Blanchette, MD, Margaret L. Rand, PhD, Barry S. Coller, MD, Andrew D. Paterson, MD, Paula D. James, MD

Blood (2017) 130 (Supplement 1): 2369.

https://doi.org/10.1182/blood.V130.Suppl_1.2369.2369

Published: 2017

Journal Articles

a Randomized, Double-Blinded, Placebo Controlled Study of IVIG Vs. IVIG with High Dose Methylprednisolone in Rapidly Augmenting Platelet Counts in Childhood ITP

Manuel Carcao, MD, Mariana Silva, MD FRCPC, Michele David, MD FRCPC, Robert J. Klaassen, MD FRCP, MacGregor Steele, MD FRCP(C), Victoria E. Price, MBChB, MD, Cindy Wakefield, Derek Stephens, MSc, Victor S. Blanchette, MD FRCPC

Blood (2016) 128 (22): 868.

https://doi.org/10.1182/blood.V128.22.868.868

Published: 2016

Journal Articles

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)

Michael D Tarantino, MD, James B. Bussel, MD, Victor S. Blanchette, MD FRCP, Jenny M. Despotovic, DO, MS, Carolyn Bennett, Ashok Raj, MD, Bronwyn Williams, Donald Beam, Jaime Morales, Melissa J. Rose, DO, Kun Nie, Melissa Eisen, MD

Blood (2015) 126 (23): 3467.

https://doi.org/10.1182/blood.V126.23.3467.3467

Published: 2015

Journal Articles

A Systematic Review of Ultrasound Imaging As a Tool for Evaluating Hemophilic Arthropathy in Children and Adults

Aryan Abadeh, Carolina de Carvalho Ligocki, Kuan Chung Wang, Thomasin Adams-Webber, Victor S. Blanchette, MD FRCP, Andrea S. Doria, MD PhD MSc

Blood (2015) 126 (23): 4464.

https://doi.org/10.1182/blood.V126.23.4464.4464

Published: 2015

Journal Articles

Hemophilia Prophylaxis No Longer Just for Children without Inhibitors - Increasing Use of Prophylaxis in Other Groups (children with inhibitors and adults with and without inhibitors)

Manuel Carcao, MD, Maria L. Avila, MD, Victor S. Blanchette, MD FRCP, Elena Santagostino, MD PhD, Carmen Escuriola-Ettingshausen, MD PhD, Cindy A. Leissinger, MD, Thierry Lambert, Louis M. Aledort, MD

Blood (2015) 126 (23): 3535.

https://doi.org/10.1182/blood.V126.23.3535.3535

Published: 2015

Journal Articles

Effect of Romiplostim on Health-Related Quality of Life in Children with Immune Thrombocytopenia and Associated Burden in Their Parents: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

Susan D Mathias, MPH, Xiaoyan Li, PhD, Melissa Eisen, MD, Nancy Carpenter, MSc, Ross D Crosby, PhD, Victor S. Blanchette, MD FRCP

Blood (2015) 126 (23): 37.

https://doi.org/10.1182/blood.V126.23.37.37

Published: 2015

Journal Articles

Modeling Minimally-Effective FVIII Trough Levels in Hemophilia a Patients on PK-Guided Prophylaxis

Gerald Spotts, PhD, Steven W. Pipe, MD, Erik Berntorp, MD PhD, Peter W. Collins, MD, Victor S. Blanchette, MD FRCPC, Kathelijn Fischer, MD PhD MSC, MyungShin Oh, Leonard A. Valentino, MD FAAP

Blood (2014) 124 (21): 689.

https://doi.org/10.1182/blood.V124.21.689.689

Published: 2014

Journal Articles

Clearance and Genetic Variability of Von Willebrand Factor Are Major Determinants of the Pharmacokinetic Behavior of Factor VIII Concentrates in the Treatment of Pediatric Hemophilia A

Kenichi Ogiwara, MD PhD, Laura L Swystun, PhD, Ilinca Georgescu, Christine Brown, Angie Tuttle, Shawn Tinlin, Jayne Leggo, Silvia Albánez, MSc, Manuel Carcao, MD MSc, Victor S. Blanchette, MD FRCPC, Christoph Male, MD MSC, Katharina Thom, David Lillicrap, MD

Blood (2014) 124 (21): 473.

https://doi.org/10.1182/blood.V124.21.473.473

Published: 2014

Journal Articles

Systematic Review of the Published Evidence on the Pharmacokinetic Characteristics of Factor VIII and IX Concentrates

Menchen Xi, Tamara Navarro-Ruan, MLIS. MD, Sunil Mammen, Victor S. Blanchette, MD FRCPC, Cedric R. Hermans, MD PhD, Massimo Morfini, MD, Peter W. Collins, MD, Kathelijn Fischer, MD PhD MSC, Ellis J. Neufeld, Guy Young, MD, Kaan Kavakli, MD, Paolo Radossi, MD, Amy Dunn, Lehana Thabane, PhD, Alfonso Iorio, MD PhD

Blood (2014) 124 (21): 2818.

https://doi.org/10.1182/blood.V124.21.2818.2818

Published: 2014

Journal Articles

PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP)

Blood (2014) 124 (21): 1450.

https://doi.org/10.1182/blood.V124.21.1450.1450

Published: 2014

Journal Articles

Feasibility Study Of a Randomized Control Trial To Evaluate An Internet-Based Self-Management Program For Adolescents With Hemophilia

Vicky R Breakey, BSc, MD, MEd, FRCPC, Danial M Ignas, BEng, Ashley Warias, BHSc, Meghan White, Victor S. Blanchette, MD, FRCPC, Jennifer Stinson, RN, PhD, CPNP

Blood (2013) 122 (21): 2921.

https://doi.org/10.1182/blood.V122.21.2921.2921

Published: 2013

Journal Articles

Prospective Comparison of the Pediatric Bleeding Questionnaire (PBQ) and the International Society On Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT) in Children Referred to a Tertiary-Care Pediatric Centre.

Veerle Labarque, MD, PhD, Victor S. Blanchette, MD, FRCPC, Dewi S. Clark, BSc, Paula D. James, MD, Margaret L. Rand, PhD

Blood (2012) 120 (21): 2229.

https://doi.org/10.1182/blood.V120.21.2229.2229

Published: 2012

Journal Articles

Reporting Bleeding Outcomes in Adult and Pediatric Studies of Primary Immune Thrombocytopenia: A Systematic Review

Nastaran Noroozi, MD, FRCPC, Cindy Neunert, MD, Jennifer K Goy, MD, George R. Buchanan, MD, Victor S. Blanchette, MD, FRCPC, Donald M. Arnold, MD, MSc.

Blood (2012) 120 (21): 4281.

https://doi.org/10.1182/blood.V120.21.4281.4281

Published: 2012

Journal Articles

Usability Testing of An Online Transition Program for Adolescents with Hemophilia

Vicky R. Breakey, BSc, MD, FRCPC, Ashley Warias, Danial M Ignas, BEng, Victor S. Blanchette, MD, FRCPC, Jennifer Stinson, BScN, PhD

Blood (2011) 118 (21): 4777.

https://doi.org/10.1182/blood.V118.21.4777.4777

Published: 2011

Journal Articles

Safety of Recombinant Activated Factor VII (rFVIIa) in Patients with Congenital Hemophilia with Inhibitors: Overall Dose Exposure and Intervals Following >240 Mcg/Kg Doses Across Trial, Registry and Diary Studies,

Amy D. Shapiro, MD, Ellis J. Neufeld, MD, PhD, Victor S. Blanchette, MD, FRCPC, Hervé Chambost, MD, PhD, Peter Salaj, MD, Robert Z. Gut, MD, PhD, David L. Cooper, MD, MBA

Blood (2011) 118 (21): 3316.

https://doi.org/10.1182/blood.V118.21.3316.3316

Published: 2011

Journal Articles

Treatment Does Not Correlate with Quality of Life in Children with Immune Thrombocytopenic Purpura: Results From the KIT International Cross-Cultural Validation Study.

Robert Klaassen, MD, John D. Grainger, MD, Arne Riedlinger, M.Phil., Victor S. Blanchette, MD, Tricia Burke, BA, Estela Citrin, MD, Gustavo Dufort y Alvarez, MD, Petronella Rachieru, MD, Josué Rakotonjanahary, MPH, Gerhard Gaedicke, MD, Cindy D. Wakefield, RN, Nancy L. Young, PhD

Blood (2009) 114 (22): 2501.

https://doi.org/10.1182/blood.V114.22.2501.2501

Published: 2009

Journal Articles

Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A.

Myungshin Oh, PhD, Sven Björkman, PhD, Phillip Schroth, Sandor Fritsch, PhD, Peter Collins, MD, Kathelijn Fischer, MD, PhD, MSc, Victor S. Blanchette, MD, Kathleen M. Casey, PhD, Gerald Spotts, PhD, Bruce M. Ewenstein, MD, PhD

Blood (2009) 114 (22): 3492.

https://doi.org/10.1182/blood.V114.22.3492.3492

Published: 2009

NARROW

Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Validation of the Modified Self-Administered Pediatric Bleeding Assessment Questionnaire (Self-PBQ) in Children Aged 8-12 Years

Results from a Prospective, Dose Escalating, Prophylaxis Study in Young Boys with Severe Hemophilia a in China: The China Hemophilia Individualized Prophylaxis Study (CHIPS) (NCT02999308)

Use of Bleeding Assessment Tools in the Diagnosis of Von Willebrand Disease: Are We Asking the Right Questions?

a Randomized, Double-Blinded, Placebo Controlled Study of IVIG Vs. IVIG with High Dose Methylprednisolone in Rapidly Augmenting Platelet Counts in Childhood ITP

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)

A Systematic Review of Ultrasound Imaging As a Tool for Evaluating Hemophilic Arthropathy in Children and Adults

Hemophilia Prophylaxis No Longer Just for Children without Inhibitors - Increasing Use of Prophylaxis in Other Groups (children with inhibitors and adults with and without inhibitors)

Effect of Romiplostim on Health-Related Quality of Life in Children with Immune Thrombocytopenia and Associated Burden in Their Parents: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

Modeling Minimally-Effective FVIII Trough Levels in Hemophilia a Patients on PK-Guided Prophylaxis

Clearance and Genetic Variability of Von Willebrand Factor Are Major Determinants of the Pharmacokinetic Behavior of Factor VIII Concentrates in the Treatment of Pediatric Hemophilia A

Systematic Review of the Published Evidence on the Pharmacokinetic Characteristics of Factor VIII and IX Concentrates

PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP)

Feasibility Study Of a Randomized Control Trial To Evaluate An Internet-Based Self-Management Program For Adolescents With Hemophilia

Prospective Comparison of the Pediatric Bleeding Questionnaire (PBQ) and the International Society On Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT) in Children Referred to a Tertiary-Care Pediatric Centre.

Reporting Bleeding Outcomes in Adult and Pediatric Studies of Primary Immune Thrombocytopenia: A Systematic Review

Usability Testing of An Online Transition Program for Adolescents with Hemophilia

Safety of Recombinant Activated Factor VII (rFVIIa) in Patients with Congenital Hemophilia with Inhibitors: Overall Dose Exposure and Intervals Following >240 Mcg/Kg Doses Across Trial, Registry and Diary Studies,

Treatment Does Not Correlate with Quality of Life in Children with Immune Thrombocytopenic Purpura: Results From the KIT International Cross-Cultural Validation Study.

Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only